California

Los Angeles, California 90048

0 studies enrolling now · 4 studies all time

What they study most

Hepatitis C, Hepatitis C, Chronic

Studies at this site

• An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients — Stopped early
• Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype — Stopped early
• A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV) — Stopped early
• Virology Follow up Study in Subjects Previously Treated With Telaprevir — Completed